Goldline Pharmaceutical Ltd
company logo

Goldline Pharmaceutical Ltd

GLPL Share Price

BSE:544759

53.94

0 (0%)

As on May 20, 2026 at 04:00 PM
Loading chart...

Performance

Loading performance...

53.94

56.77

21000

0.11

10

Fundamentals

51.78Cr

0

2.57

1.22

0

0%

21.00

About

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f. September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand. Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente. The pharmaceutical products marketed under the 'Goldline' brand are not manufactured by Company. Instead, they enter into contractual arrangements with third-party manufacturers, who produce the products based on market research, demand analysis, and specifications. Presently, Company maintain contractual arrangements with 15 manufacturers and 7 distributors, ensuring a stable supply chain and consistent market presence. Company extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through the promoter group entities as Numerius Healthcare Pvt Ltd & Activista Healthcare Pvt Ltd, Company manage trading and supply chain operations, thereby ensuring reliable procurement, seamless distribution, and logistical efficiency. Company is planning the Initial Public Offer of 30,00,000 Equity Shares having the face value of Rs 10 each through Fresh Issue.

2004

NameDesignation
AMOL LAXMIKANT MUJUMDARChairman / Executive Director / M D / Promoter
Swapan Prernprakash KhandelwalWTD & Executive Director
Prashant Shriknshna KarkareExecutive Director
Avinash Pandurang AmbulkarExecutive Director
Prashant Vithal RahateNon Executive Director
Mehul Hari RanadeIndependent Non Exe. Director
Renuka Saurabh BoroleIndependent Non Exe. Director
Shraddha Kiran KulkarniIndependent Non Exe. Director
Ruchi Sanket ModiCompany Sec. & Compli. Officer

Goldline Pharmaceutical Ltd FAQs

How do I Buy Goldline Pharmaceutical Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Goldline Pharmaceutical Ltd shares in BlinkX.

What is the Share Price of Goldline Pharmaceutical Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Goldline Pharmaceutical Ltd's share price is ₹53.94 as of 2026-05-20.

What is the PE ratio of Goldline Pharmaceutical Ltd?

close

Goldline Pharmaceutical Ltd's P/E ratio is - times as of 2026-05-20.

What is the PB ratio of Goldline Pharmaceutical Ltd?

close

Goldline Pharmaceutical Ltd's most recent financial reports indicate a price-to-book ratio of 2.57, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Goldline Pharmaceutical Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Goldline Pharmaceutical Ltd's market capitalization is ₹51.78 Cr as on 2026-05-20.

What is the ROE of Goldline Pharmaceutical Ltd?

close

The current financial records of Goldline Pharmaceutical Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Goldline Pharmaceutical Ltd?

close

According to Goldline Pharmaceutical Ltd's most recent financial filings, the company has a total asset value of ₹23.35, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Goldline Pharmaceutical Ltd?

close

The 52-week high/low price of a Goldline Pharmaceutical Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Goldline Pharmaceutical Ltd's 52-week high and low as of 2026-05-20 are ₹60 and ₹53.94, respectively.